DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Amdoxovir is an investigational drug.
There have been 5 clinical trials for Amdoxovir. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Virus Diseases. The leading clinical trial sponsors are RFS Pharma, LLC, National Institute of Allergy and Infectious Diseases (NIAID), and [disabled in preview].
There are five hundred and one US patents protecting this investigational drug and five international patents.
Recent Clinical Trials for Amdoxovir
|A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects||RFS Pharma, LLC||Phase 2|
|A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.||RFS Pharma, LLC||Phase 2|
|Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV||RFS Pharma, LLC||Phase 1/Phase 2|
Top disease conditions for Amdoxovir
Top clinical trial sponsors for Amdoxovir
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Amdoxovir||Start Trial||Pharmaceutical antiretroviral composition||Cipla Limited (Mumbai, IN)||Start Trial|
|Amdoxovir||Start Trial||Method of preparing carboxylic acid functionalized polymers||NEKTAR THERAPEUTICS (San Francisco, CA)||Start Trial|
|Amdoxovir||Start Trial||Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same||STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM)||Start Trial|
|Amdoxovir||Start Trial||Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections||EMORY UNIVERSITY (Atlanta, GA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|